Hanmi Pharm. Co., Ltd.
Símbolo: 128940.KS
KSC
322000
KRWPrecio de mercado actual
24.3478
Ratio PER
0.0155
Ratio PEG
4.09T
Capitalización MRK
- 0.00%
Rendimiento DIV
Hanmi Pharm. Co., Ltd. (128940-KS) Estados Financieros
Balance de situación
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1054695.09 | 254155.7 | 236736.4 | 211734.4 | ||||||||||||||
balance-sheet.row.short-term-investments | 473033.11 | 199175.4 | 89407.8 | 2509.7 | ||||||||||||||
balance-sheet.row.net-receivables | 654118.15 | 179195.9 | 191163.2 | 241982 | ||||||||||||||
balance-sheet.row.inventory | 1195313.85 | 288813.8 | 266185.4 | 250188.7 | ||||||||||||||
balance-sheet.row.other-current-assets | 26673.46 | 26487.6 | 73.2 | 56.5 | ||||||||||||||
balance-sheet.row.total-current-assets | 2930800.55 | 748652.9 | 694158.3 | 703961.6 | ||||||||||||||
balance-sheet.row.property-plant-equipment-net | 3522544.62 | 860242 | 917981.5 | 957218.2 | ||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.intangible-assets | 336258.22 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 336258.22 | 81045.2 | 84586.8 | 80169.6 | ||||||||||||||
balance-sheet.row.long-term-investments | -25812.15 | 47756 | -17742 | 50416.9 | ||||||||||||||
balance-sheet.row.tax-assets | 441171 | 159972 | 89901.6 | 91855.8 | ||||||||||||||
balance-sheet.row.other-non-current-assets | 522034.7 | 54367 | 155699.5 | 53106.5 | ||||||||||||||
balance-sheet.row.total-non-current-assets | 4796196.39 | 1203382.2 | 1230427.5 | 1232767.1 | ||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.total-assets | 7726996.94 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.account-payables | 180134.18 | 45180.3 | 39709.5 | 42833.4 | ||||||||||||||
balance-sheet.row.short-term-debt | 1852780.43 | 483775.4 | 489193 | 455166.9 | ||||||||||||||
balance-sheet.row.tax-payables | 61697.03 | 6741.6 | 22180.1 | 26475 | ||||||||||||||
balance-sheet.row.long-term-debt-total | 554364.62 | 82028.4 | 225815.6 | 301099.8 | ||||||||||||||
Deferred Revenue Non Current | 22620.81 | 1033.1 | 8457.6 | 10839.7 | ||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 60594.59 | - | - | - | ||||||||||||||
balance-sheet.row.other-current-liab | 315823.47 | 150970.5 | 131195.3 | 0 | ||||||||||||||
balance-sheet.row.total-non-current-liabilities | 652005.05 | 146408.2 | 238610.7 | 359531 | ||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.capital-lease-obligations | 39142.78 | 7063.4 | 48215.1 | 65622.2 | ||||||||||||||
balance-sheet.row.total-liab | 3396654.42 | 851824.4 | 915359 | 1008469.3 | ||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||
balance-sheet.row.common-stock | 125621.58 | 31405.4 | 30794.9 | 30195.7 | ||||||||||||||
balance-sheet.row.retained-earnings | 1886749.09 | 336059.3 | 452297.5 | 396915.9 | ||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 254298.95 | 216059.6 | 232729.4 | 200479.4 | ||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1487672.63 | 371918.2 | 156043.8 | 175322.8 | ||||||||||||||
balance-sheet.row.total-stockholders-equity | 3754342.25 | 955442.4 | 871865.6 | 802913.7 | ||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 7726996.94 | 1952035.1 | 1924585.7 | 1936728.7 | ||||||||||||||
balance-sheet.row.minority-interest | 576000.27 | 144768.3 | 137361.1 | 125345.7 | ||||||||||||||
balance-sheet.row.total-equity | 4330342.52 | 1100210.6 | 1009226.7 | 928259.4 | ||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 7726996.94 | - | - | - | ||||||||||||||
Total Investments | 447220.96 | 246931.4 | 71665.7 | 52926.7 | ||||||||||||||
balance-sheet.row.total-debt | 2414208.48 | 572867.3 | 715008.6 | 756266.7 | ||||||||||||||
balance-sheet.row.net-debt | 1832546.5 | 517886.9 | 567680 | 547042.1 |
Estado de tesorería
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 163352.08 | 146231.2 | 101558.2 | 81478.2 | ||||||||||||||
cash-flows.row.depreciation-and-amortization | 98453.98 | 98454 | 96842 | 89086.3 | ||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.change-in-working-capital | -57396.64 | -57396.6 | -73686.3 | -53516.2 | ||||||||||||||
cash-flows.row.account-receivables | -2602.85 | -2602.8 | 38190.1 | -74313.9 | ||||||||||||||
cash-flows.row.inventory | -16902.57 | -16902.6 | -14365.3 | 18915.7 | ||||||||||||||
cash-flows.row.account-payables | 5574.24 | 5574.2 | -2736.1 | 9794.1 | ||||||||||||||
cash-flows.row.other-working-capital | -43465.46 | -43465.5 | -94774.9 | -7912.1 | ||||||||||||||
cash-flows.row.other-non-cash-items | 12128.2 | 29249.1 | 37555 | 84874.8 | ||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 216537.62 | 0 | 0 | 0 | ||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -45006.33 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.acquisitions-net | -2329.26 | 2600.2 | -25772 | -14112.3 | ||||||||||||||
cash-flows.row.purchases-of-investments | -94870.16 | -94770.2 | -92923.2 | -7738.6 | ||||||||||||||
cash-flows.row.sales-maturities-of-investments | 112084.31 | 90377.5 | 86.6 | 785.9 | ||||||||||||||
cash-flows.row.other-investing-activites | -153350.76 | -133933.2 | -13206.4 | 12101.1 | ||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -183472.2 | -183472.2 | -181408.1 | -43388.8 | ||||||||||||||
cash-flows.row.debt-repayment | -227050 | -103371 | -260971.4 | -232371.4 | ||||||||||||||
cash-flows.row.common-stock-issued | 0 | 93.5 | 0 | 0 | ||||||||||||||
cash-flows.row.common-stock-repurchased | -3070.61 | -3070.6 | -3834.1 | -4873.5 | ||||||||||||||
cash-flows.row.dividends-paid | -577.92 | -17995.6 | -5992.2 | -5881.3 | ||||||||||||||
cash-flows.row.other-financing-activites | 122485.36 | -2443 | 233930.9 | 129795.6 | ||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -126786.67 | -126786.7 | -36866.8 | -113330.6 | ||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 1372.92 | 1372.9 | -5890 | 17863.5 | ||||||||||||||
cash-flows.row.net-change-in-cash | -92348.33 | -92348.3 | -61896 | 63067.3 | ||||||||||||||
cash-flows.row.cash-at-end-of-period | 581661.98 | 54980.3 | 147328.7 | 209224.6 | ||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 674010.31 | 147328.7 | 209224.6 | 146157.4 | ||||||||||||||
cash-flows.row.operating-cash-flow | 216537.62 | 216537.6 | 162268.9 | 201923.2 | ||||||||||||||
cash-flows.row.capital-expenditure | -45006.33 | -47746.5 | -49593.1 | -34424.9 | ||||||||||||||
cash-flows.row.free-cash-flow | 171531.29 | 168791.1 | 112675.9 | 167498.3 |
Fila de la Cuenta de Resultados
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 1533382.91 | 1490887.5 | 1331546.6 | 1203185.7 | ||||||||||||||
income-statement-row.row.cost-of-revenue | 504860.91 | 655030.7 | 612993.5 | 570433.4 | ||||||||||||||
income-statement-row.row.gross-profit | 1028522 | 835856.7 | 718553.1 | 632752.2 | ||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||
income-statement-row.row.research-development | 143131.5 | - | - | - | ||||||||||||||
income-statement-row.row.selling-general-administrative | 302881.21 | - | - | - | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 134845.54 | - | - | - | ||||||||||||||
income-statement-row.row.other-expenses | -903007.86 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.operating-expenses | 209441.9 | 610971.8 | 560462.7 | 507336.4 | ||||||||||||||
income-statement-row.row.cost-and-expenses | 1002662.32 | 1266002.5 | 1173456.3 | 1077769.8 | ||||||||||||||
income-statement-row.row.interest-income | 2934.98 | 4617.7 | 7856.4 | 5722.3 | ||||||||||||||
income-statement-row.row.interest-expense | 21182.66 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 134845.54 | - | - | - | ||||||||||||||
income-statement-row.row.total-other-income-expensenet | -28726.86 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||
income-statement-row.row.other-operating-expenses | -903007.86 | 12396.2 | 172512.1 | 147929 | ||||||||||||||
income-statement-row.row.total-operating-expenses | -28726.86 | -29617.3 | -37077.8 | -21719.4 | ||||||||||||||
income-statement-row.row.interest-expense | 21182.66 | 28508.4 | 22647.1 | 16576.8 | ||||||||||||||
income-statement-row.row.depreciation-and-amortization | 312979.32 | 98454 | 97942.5 | 87056.1 | ||||||||||||||
income-statement-row.row.ebitda-caps | 555340.39 | - | - | - | ||||||||||||||
income-statement-row.row.operating-income | 242361.07 | 224884.9 | 158090.3 | 125415.9 | ||||||||||||||
income-statement-row.row.income-before-tax | 213634.21 | 195267.6 | 121012.5 | 103696.5 | ||||||||||||||
income-statement-row.row.income-tax-expense | 34746.69 | 28600.6 | 19454.3 | 22218.3 | ||||||||||||||
income-statement-row.row.net-income | 166279.43 | 146231.2 | 82791.7 | 67025.4 |
Preguntas frecuentes
Cuánto es Hanmi Pharm. Co., Ltd. (128940.KS) activos totales?
Hanmi Pharm. Co., Ltd. (128940.KS) los activos totales son 1952035090968.000.
¿Cuáles son los ingresos anuales de la empresa?
Los ingresos anuales son 826034745318.000.
¿Cuál es el margen de beneficios de la empresa?
El margen de beneficios de la empresa es 0.671.
¿Qué es el flujo de caja libre de la empresa?
El flujo de caja libre es 13515.617.
¿Cuál es el margen de beneficio neto de la empresa?
El margen de beneficio neto es 0.108.
¿Cuáles son los ingresos totales de la empresa?
Los ingresos totales son 0.158.
¿Qué es Hanmi Pharm. Co., Ltd. (128940.KS) beneficio neto (ingresos netos)?
El beneficio neto (ingresos netos) es 146231157740.000.
¿Cuál es la deuda total de la empresa?
La deuda total es 572867266550.000.
¿Cuál es la cifra de gastos de explotación?
Los gastos de explotación son 610971802715.000.
¿Cuál es la cifra de tesorería de la empresa?
La tesorería de la empresa es 54980324303.000.